Hygieia Extends Series B Round to $22 Million with Participation from Strategic Investors
Press Release Hygieia, a digital therapeutics company for insulin therapy, is extending its Series B funding round to $22 million with a lead investment from Firstime Ventures and additional investment from two strategic partners.Hygieia is the maker of d-Nav®, the…